Saadaat Ramin, Adelyar Mohammad Asef, Rasool Esmatullah Esmat, Abdul-Ghafar Jamshid, Haidary Ahmed Maseh
Department of Pathology and Clinical Laboratory, French Medical Institute for Mothers and Children (FMIC), Kabul, Afghanistan.
Department of Internal Medicine, French Medical Institute for Mothers and Children (FMIC), Kabul, Afghanistan.
Int J Surg Case Rep. 2023 Mar;104:107942. doi: 10.1016/j.ijscr.2023.107942. Epub 2023 Feb 17.
Malignant melanoma of the gastrointestinal tract is an extremely rare event of which 50 % occurs in anorectal region. The lesion can easily be misdiagnosed as rectal-carcinoma, which comprises >90 % of rectal tumors and has a different treatment. The behavior of the anorectal melanoma is very aggressive and has very poor prognosis with fatal outcome.
A 48-year-old man presented complaining of rectal bleeding of two months' duration, without any other significant history. Colonoscopy showed a polypoidal mass in the rectum that was in favor of adenocarcinoma. The microscope examination of biopsy tissue showed sheets of poorly differentiated malignant neoplasm. Immuno-histochemical (IHC) staining showed negativity of pan Cytokeratin and CD31. IHC for HMB45 showed diffuse and strong positivity in neoplastic cells, confirming the diagnosis of malignant melanoma.
According to a report by the National Cancer Database of the United States, primary rectal melanoma is very rare. Mucosal surface of the body is third most common site for primary melanoma after skin and eye. The first case of anorectal melanoma was reported in 1857. Histopathological examinations are gold standard for diagnosis, but histopathology examination without immunohistochemistry will misdiagnose some cases as poorly differentiated adenocarcinoma which has completely different treatment. Surgical resection has been reported as the most useful treatment option.
Malignant melanoma of the rectum is extremely rare and difficult to diagnose in low resources settings. Histopathologic examination with IHC stains can differentiate poorly differentiated adenocarcinoma from melanoma and other rare tumors of anorectal region.
胃肠道恶性黑色素瘤极为罕见,其中50%发生于肛管直肠区域。该病变很容易被误诊为直肠癌,直肠癌占直肠肿瘤的90%以上,且治疗方法不同。肛管直肠黑色素瘤的行为极具侵袭性,预后很差,往往导致致命后果。
一名48岁男性因持续两个月的直肠出血前来就诊,无其他重要病史。结肠镜检查显示直肠有一个息肉样肿物,倾向于腺癌。活检组织的显微镜检查显示为成片的低分化恶性肿瘤。免疫组织化学(IHC)染色显示泛细胞角蛋白和CD31均为阴性。HMB45的IHC染色显示肿瘤细胞弥漫性强阳性,确诊为恶性黑色素瘤。
根据美国国家癌症数据库的一份报告,原发性直肠黑色素瘤非常罕见。身体黏膜表面是继皮肤和眼睛之后原发性黑色素瘤的第三大常见部位。1857年报道了首例肛管直肠黑色素瘤。组织病理学检查是诊断的金标准,但没有免疫组织化学的组织病理学检查会将一些病例误诊为低分化腺癌,而两者的治疗方法完全不同。据报道,手术切除是最有效的治疗选择。
直肠恶性黑色素瘤极为罕见,在资源匮乏地区难以诊断。采用IHC染色的组织病理学检查可以区分低分化腺癌与黑色素瘤以及肛管直肠区域的其他罕见肿瘤。